Analyze Diet
Journal of labelled compounds & radiopharmaceuticals2025; 68(3); e4132; doi: 10.1002/jlcr.4132

Synthesis and Characterization of 3-Hydroxybupivacaine and Deuterated 3-Hydroxybupivacaine for Use in Equine Medication Regulation.

Abstract: Bupivacaine is a local anesthetic widely used in equine and human medicine. Use of bupivacaine in performance horses is regulated because its ability to block pain means that it can be misused for advantage in performance horses. In racing regulation, bupivacaine is classified by the Association of Racing Commissioners International (ARCI) as a Class 2 Penalty Class A Foreign substance, the detection of which can lead to significant penalties. In horses, bupivacaine is metabolized by Phase-I hydroxylation to yield 3-hydroxybupivacaine, which is then glucuronidated to yield the Phase-II metabolite bupivacaine-3-hydroxyglucuronide, which is excreted at relatively high concentrations in equine urine. Standard regulatory procedure during urinalysis is to perform an enzymatic hydrolysis, thereby enabling subsequent detection of 3-hydroxybupivacaine, the primary analyte used for bupivacaine regulation in urine samples from competition horses. We now report on the synthesis of 3-hydroxybupivacaine and deuterated 3-hydroxybupivacaine from piperidine-2-carboxylic acid in six successive steps with moderate yield. The compounds were characterized by H and C NMR and their purity ascertained by HPLC-MS. The deuterated bupivacaine and 3-hydroxybupivacaine were further confirmed by HRMS. The synthesis of these compounds provides certified reference standards and stable isotope-labeled internal standards for drug testing in competitive equine sports including horse racing.
Publication Date: 2025-03-04 PubMed ID: 40035476DOI: 10.1002/jlcr.4132Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Objective Overview

  • This research paper presents the synthesis and characterization of 3-hydroxybupivacaine and its deuterated form, designed to aid in the regulation of bupivacaine use in competitive horses by providing accurate standards for drug testing.

Introduction and Background

  • Bupivacaine Usage: Bupivacaine is a local anesthetic commonly used in both equine and human medicine for pain management.
  • Regulations in Horse Racing: Because bupivacaine can mask pain, its use in racehorses is tightly regulated to prevent unfair advantage; it is classified by the Association of Racing Commissioners International (ARCI) as a Class 2 Penalty Class A Foreign substance.
  • Metabolism in Horses: In horses, bupivacaine undergoes Phase-I metabolism resulting in 3-hydroxybupivacaine. In Phase-II, this metabolite is glucuronidated to form bupivacaine-3-hydroxyglucuronide, which is excreted in urine in substantial amounts.
  • Drug Testing Challenges: Standard urinalysis includes enzymatic hydrolysis to break down glucuronides, enabling detection of 3-hydroxybupivacaine—the main target analyte for regulation checks.

Synthesis of 3-Hydroxybupivacaine and Deuterated Analog

  • Starting Material: The synthesis began with piperidine-2-carboxylic acid, chosen as the precursor molecule.
  • Synthetic Route: A six-step chemical synthesis was carried out to produce both 3-hydroxybupivacaine and its deuterated variant.
  • Deuteration Purpose: The introduction of deuterium atoms allows creation of isotopically labeled versions used as internal standards in mass spectrometry-based drug testing, improving quantification accuracy.
  • Yield: The synthesis provided moderate yields of both compounds, indicating an efficient and practical process for producing these standards.

Characterization and Verification

  • NMR Analysis: Proton (¹H) and Carbon (¹³C) Nuclear Magnetic Resonance spectroscopy were utilized to confirm the chemical structures of the synthesized molecules.
  • Purity Assessment: High-Performance Liquid Chromatography coupled with Mass Spectrometry (HPLC-MS) was employed to verify purity levels suitable for use as reference standards.
  • High-Resolution Mass Spectrometry (HRMS): Further confirmation of the deuterated version and identity of the compounds was achieved through HRMS analysis, providing precise molecular weight and isotopic patterns.

Significance and Applications

  • Regulatory Utility: These synthesized compounds serve as certified reference standards, enabling laboratories to accurately detect and measure bupivacaine metabolites in equine urine.
  • Stable Isotope-Labeled Standards: The deuterated 3-hydroxybupivacaine is used as an internal standard during mass spectrometry, compensating for variability in sample preparation and instrument response, thus enhancing testing reliability.
  • Impact on Equine Sports: This research supports fair competition in horse racing by improving the ability to monitor unauthorized use of pain-masking drugs effectively through precise biochemical testing.

Cite This Article

APA
Arojojoye AS, Holmes J, Buchart MP, Awuah SG, Eisenberg R, Fenger CK, Maylin GA, Tobin T. (2025). Synthesis and Characterization of 3-Hydroxybupivacaine and Deuterated 3-Hydroxybupivacaine for Use in Equine Medication Regulation. J Labelled Comp Radiopharm, 68(3), e4132. https://doi.org/10.1002/jlcr.4132

Publication

ISSN: 1099-1344
NlmUniqueID: 7610510
Country: England
Language: English
Volume: 68
Issue: 3
Pages: e4132

Researcher Affiliations

Arojojoye, Adedamola S
  • Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.
Holmes, Justin
  • Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.
Buchart, Miles P
  • The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center, Martin-Gatton College of Agriculture, Food and Environment and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.
Awuah, Samuel G
  • Department of Chemistry, University of Kentucky, Lexington, Kentucky, USA.
  • Center for Pharmaceutical Research and Innovation, College of Pharmacy and Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.
Eisenberg, Rodney
  • Frontier BioPharm, LLC, Richmond, Kentucky, USA.
Fenger, Clara K
  • Equine Integrated Medicine, Georgetown, Kentucky, USA.
Maylin, George A
  • New York Drug Testing and Research Program, Ithaca, New York, USA.
Tobin, Thomas
  • The Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center, Martin-Gatton College of Agriculture, Food and Environment and the Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA.

MeSH Terms

  • Horses
  • Animals
  • Bupivacaine / analogs & derivatives
  • Bupivacaine / chemical synthesis
  • Bupivacaine / chemistry
  • Bupivacaine / urine
  • Deuterium / chemistry
  • Chemistry Techniques, Synthetic
  • Doping in Sports
  • Anesthetics, Local / chemical synthesis
  • Anesthetics, Local / chemistry

Grant Funding

  • KY014066 / National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch Program

References

This article includes 28 references
  1. ICH Draft, Guideline M10 on Bioanalytical Method Validation (European Medicines Agency, 2019).
  2. Mutlib AE. Application of Stable Isotope‐Labeled Compounds in Metabolism and in Metabolism‐Mediated Toxicity Studies. Chemical Research in Toxicology 21 (2008): 1672–1689.
  3. Pailleux F, Beaudry F. Internal Standard Strategies for Relative and Absolute Quantitation of Peptides in Biological Matrices by Liquid Chromatography Tandem Mass Spectrometry. Biomedical Chromatography 26 (2012): 881–891.
  4. Nakahara Y, Takahashi K, Shimamine M, Takeda Y. Hair Analysis for Drug Abuse: I. Determination of Methamphetamine and Amphetamine in Hair by Stable Isotope Dilution Gas Chromatography/Mass Spectrometry Method. Journal of Forensic Sciences 36 (1991): 70–78.
  5. Kuepper U, Musshoff F, Hilger RA, Herbstreit F, Madea B. Pharmacokinetic Properties of Succinylmonocholine in Surgical Patients. Journal of Analytical Toxicology 35 (2011): 302–311.
  6. Yokokawa A, Yamamoto K, Omori Y. Simultaneous Determination of Androstenedione, 11β‐Hydroxyandrostenedione, and Testosterone in Human Plasma by Stable Isotope Dilution Mass Spectrometry. Journal of Chromatography B 877 (2009): 621–626.
  7. Bronsema KJ, Bischoff R, van de Merbel NC. Internal Standards in the Quantitative Determination of Protein Biopharmaceuticals Using Liquid Chromatography Coupled to Mass Spectrometry. Journal of Chromatography B 893 (2012): 1–14.
  8. Kudrimoti S, Machin J, Arojojoye AS. Synthesis and Characterization of d5‐Barbarin for use in Barbarin‐Related Research. Drug Testing and Analysis 15 (2023): 42–46.
  9. Thomas C, Burns N. Principles of Pharmacology for Athletic Trainers. (Routledge, 2024): 346–380.
  10. Thevis M, Piper T, Horning S, Juchelka D, Schänzer W. Hydrogen Isotope Ratio Mass Spectrometry and High‐Resolution/High‐Accuracy Mass Spectrometry in Metabolite Identification Studies: Detecting Target Compounds for Sports Drug Testing. Rapid Communications in Mass Spectrometry 27 (2013): 1904–1912.
  11. Carpenter RE, Byron CR. Equine Local Anesthetic and Analgesic Techniques. in Veterinary Anesthesia and Analgesia: The Fifth Edition of Lumb and Jones, (Wiley‐Blackwell, 2015): 886–911.
  12. Moreira F, Carmo H, Guedes de Pinho P, d L Bastos M. Doping Detection in Animals: A Review of Analytical Methodologies Published From 1990 to 2019. Drug Testing and Analysis 13 (2021): 474–504.
  13. Toby MC. Unnatural Ability: The History of Performance‐Enhancing Drugs in Thoroughbred Racing. (University Press of Kentucky, 2023).
  14. Doherty TJ, Seddighi MR. Local Anesthetics as Pain Therapy in Horses. Veterinary Clinics: Equine Practice 26 (2010): 533–549.
  15. Tobin T. Drugs and the Performance Horse; Charles C. Thomas. (1981).
  16. Harkins J, Mundy G, Stanley S. Determination of Highest No Effect Dose (HNED) for Local Anaesthetic Responses to Procaine, Cocaine, Bupivacaine and Benzocaine. Equine Veterinary Journal 28 (1996): 30–37.
  17. Harkins JD, Lehner A, Karpiesiuk W. Bupivacaine in the Horse: Relationship of Local Anaesthetic Responses and Urinary Concentrations of 3‐Hydroxybupivacaine. Journal of Veterinary Pharmacology and Therapeutics 22 (1999): 181–195.
  18. Tobin T, Harkins J, Sams R. Testing for Therapeutic Medications: Analytical/Pharmacological Relationships and Limitations' on the Sensitivity of Testing for Certain Agents. Journal of Veterinary Pharmacology and Therapeutics 22 (1999): 220–233.
  19. Rules AM. Association of Racing Commissioners International Uniform Classification Guidelines for Foreign Substances and Recommended Penalties Model Rule. (2023).
  20. Combie J, Blake J, Nugent TE, Tobin T. Morphine Glucuronide Hydrolysis: Superiority of Beta‐Glucuronidase From Patella vulgata. Clinical Chemistry 28 (1982): 83–86.
  21. Combie JD, Blake JW, Nugent TE, Tobin T. Google Patents. (1984).
  22. Tobin KB, Kent H. Stirling World Rules for Equine Drug Testing and Therapeutic Medication Regulation Policy of the National Horsemen's Benevolent and Protective Association. Nicholasville KY: Wind Publications: 600 Overbrook Drive, 2012.
  23. McCracken MJ, Schumacher J, Doherty TJ, Sun X, Nichols CL, Olivarez J. Efficacy and Duration of Effect for Liposomal Bupivacaine When Administered Perineurally to the Palmar Digital Nerves of Horses. American Journal of Veterinary Research 81 (2020): 400–405.
  24. Knych H, Mama K, Moore C, Hill A, McKemie D. Plasma and Synovial Fluid Concentrations and Cartilage Toxicity of Bupivacaine Following Intra‐Articular Administration of a Liposomal Formulation to Horses. Equine Veterinary Journal 51 (2019): 408–414.
  25. Gilfoyle D. Veterinary Immunology as Colonial Science: Method and Quantification in the Investigation of Horsesickness in South Africa, c. 1905–1945. Journal of the History of Medicine and Allied Sciences 61 (2006): 26–65.
  26. Derry ME. Horses in Society: A Story of Animal Breeding and Marketing Culture, 1800–1920. University of Toronto Press, 2016.
  27. Franchini C, Corbo F, Lentini G. Synthesis of New 2, 6‐Prolylxylidide Analogues of Tocainide as Stereoselective Blockers of Voltage‐Gated Na+ Channels With Increased Potency and Improved Use‐Dependent Activity. Journal of Medicinal Chemistry 43 (2000): 3792–3798.
  28. Falany CN, Falany JL, Wang J, Hedström J, von Euler Chelpin H, Swedmark S. Studies on Sulfation of Synthesized Metabolites From the Local Anesthetics Ropivacaine and Lidocaine Using Human Cloned Sulfotransferases. Drug Metabolism and Disposition 27 (1999): 1057–1063.

Citations

This article has been cited 0 times.